Preview

Genij Ortopedii

Advanced search

Pathomorphologic evaluation of intra-articular injections of soluble platelet-rich plasma for treatment of experimental osteoarthritis

https://doi.org/10.18019/1028-4427-2024-30-1-90-98

EDN: WNDTZQ

Abstract

Introduction Non-surgical treatment of osteoarthritis is aimed at managing joint degeneration and inflammation to prolong the life of the original joint and delay total joint replacement. The objective was to pathomorphologically substantiate preclinical effectiveness of PRP in OA using comparative analysis of depleted plasma and serum.

Material and methods The experiment was performed in 120 Wistar rats, divided into 4 groups. Osteoarthritis was simulated using an original method. Knee joint injection given to the animals after skin dissection under inhalation anesthesia and visual control two weeks later contained 0.05 ml PRP in group 1, 0.05 ml plasma in groups 2 and 0.05 ml blood serum in groups 3. The same volume of physiological saline solution was used for the injections produced for control animals. Injections were administered three times at 2-week intervals. Animals were sacrificed in groups of 10 at 2 weeks of each injection.

Results The median MANKIN value scored 2.0 (1.0; 2.0) in group 1, 6.0 (5.0; 7.0) in group 2 and 7.0 (6.0; 7.0) in group 3 at 6 weeks. The median MANKIN value scored 7.5 (7.0, 8.0) in the control group. Statistically significant differences were determined between the groups at p < 0.001.

Discussion Literature data on preclinical evaluation of the effectiveness of PRP therapy in biological models of OA are controversial. An original, low-traumatic functional method was used for simulating knee OA to reproduce major pathogenetic mechanisms in rats.

Conclusion The findings suggested a pronounced therapeutic effect with improved morphofunctional features of the hyaline cartilage and MANKIN score of 2 at 6 days of intra-articular administration of modified PRP as compared with plasma and serum.

About the Authors

A. A. Tretyakov
Gomel State Medical University
Belarus

Alexander A. Tretyakov – Senior lecturer.

Gomel



D. A. Zinovkin
Gomel State Medical University
Belarus

Dimitry A. Zinovkin – Candidate of Biological Sciences, Associate Professor.

Gomel



F. N. Karpenko
Republic Research and Production Center for Transfusiology and Medical Biotechnologies
Belarus

Fedor N. Karpenko – Candidate of Medical Sciences, Director.

Minsk



M. P. Potapnev
Republic Research and Production Center for Transfusiology and Medical Biotechnologies
Belarus

Mikhail P. Potapnev – Doctor of Medical Sciences, Professor.

Minsk



V. I. Nikolaev
Gomel State Medical University
Belarus

Vladimir I. Nikolaev – Candidate of Medical Sciences, Associate Professor.

Gomel



M. Z.I. Pranjol
School of Life Science, University of Sussex
United Kingdom

Midi Zahidul I. Pranjol – MD, Associate Professor, Senior lecturer.

Brighton



References

1. Wu PI, Diaz R, Borg-Stein J. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-853. doi: 10.1016/j.pmr.2016.06.002

2. Cole BJ, Karas V, Hussey K, et al. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2017;45(2):339-346. doi: 10.1177/0363546516665809

3. Эйсмонт О.Л. Ортобиологические технологии в лечении остеоартрита суставов. Медицинские новости. 2020;8(311):45-48.

4. Laver L, Marom N, Dnyanesh L, et al. PRP for Degenerative Cartilage Disease: A Systematic Review of Clinical Studies. Cartilage. 2017;8(4):341-364. doi: 10.1177/1947603516670709

5. Joshi Jubert N, Rodríguez L, Reverté-Vinaixa MM, Navarro A. Platelet-Rich Plasma Injections for Advanced Knee Osteoarthritis: A Prospective, Randomized, Double-Blinded Clinical Trial. Orthop J Sports Med. 2017;5(2):2325967116689386. doi: 10.1177/2325967116689386

6. Fox BA, Stephens MM. Treatment of knee osteoarthritis with Orthokine-derived autologous conditioned serum. Expert Rev Clin Immunol. 2010;6(3):335-345. doi: 10.1586/eci.10.17

7. Frisbie DD, Kawcak CE, Werpy NM, et al. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 2007;68(3):290-296. doi: 10.2460/ajvr.68.3.290

8. Österdahl J. Evaluation of autologous conditioned serum. Swed Uni Agricultural Sci. 2008;(3):1-5.

9. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638-646. doi: 10.1016/s1079-2104(98)90029-4

10. Котлубаева Э.Ю., Белашов Н.В., Лапынин А.И. К вопросу об истории применения и эффективности PRP-терапии. Научный альманах. 2020;(1-2(63)):69-72. Доступно по: https://ukonf.com/doc/na.2020.01.02.pdf. Ссылка активна на 25.10.2024.

11. Потапнев М.П., Загородный Г.М., Кривенко С.И., и др. Современные аспекты применения плазмы, обогащенной растворимыми факторами тромбоцитов, в лечении травм и заболеваний опорно-двигательного аппарата. Спортивная медицина: наука и практика. 2019;9(4):33-45. doi: 10.17238/ISSN2223-2524.2019.4.33

12. Yamaguchi R, Terashima H, Yoneyama S, et al. Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. J Surg Res. 2012;173(2):258-66. doi: 10.1016/j.jss.2010.10.001

13. Николаев В.И., Петкевич О.В., Третьяков А.А. и др. Способ экспериментального моделирования остеоартроза коленного сустава у крысы. Патент Респ. Беларусь № 23186. 30.06.2010. Доступно по: https://elib.gsmu.by/handle/GomSMU/3486. Ссылка активна на 25.10.2023.

14. Park YG, Han SB, Song SJ, et fl. Platelet-rich plasma therapy for knee joint problems: review of the literature, current practice and legal perspectives in Korea. Knee Surg Relat Res. 2012;24(2):70-8. doi: 10.5792/ksrr.2012.24.2.70

15. Троянов А.А., Потапнев М.П., Кондратенко Г.Г., и др. Биологические эффекты и ранозаживляющее действие плазмы, обогащенной растворимыми факторами тромбоцитов, в условиях экспериментальной гипергликемии. Медицинский журнал. 2018;(2):107-112.

16. Hanafy AS, El-Ganainy SO. Thermoresponsive Hyalomer intra-articular hydrogels improve monoiodoacetate-induced osteoarthritis in rats. Int J Pharm. 2020;573:118859. doi: 10.1016/j.ijpharm.2019.118859

17. Bansal H, Leon J, Pont JL, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci Rep. 2021;11(1):3971. doi: 10.1038/s41598-021-83025-2

18. Magalon J, Chateau AL, Bertrand B, et al. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med. 2016;2(1):e000060. doi: 10.1136/bmjsem-2015-000060

19. Потапнев М.П., Кривенко С.И., Богдан В.Г., и др. Плазма крови, обогащенная растворимыми факторами тромбоцитов: получение, стандартизация, медицинское применение. Здравоохранение. 2018;10(859): 38-44.

20. Boffa A, Salerno M, Merli G, et al. Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models. Knee Surg Sports Traumatol Arthrosc. 2021;29(12):4100-4121. doi: 10.1007/s00167-021-06659-9

21. Asjid R, Faisal T, Qamar K, et al. Effect of Platelet-rich Plasma on Mankin Scoring in Chemically-induced Animal Model of Osteoarthritis. J Coll Physicians Surg Pak. 2019;29(11):1067-1071. doi: 10.29271/jcpsp.2019.11.1067

22. Papalia R, Diaz Balzani L, Torre G, et al. Intraoperative application Platelet rich fibrin, postoperative injections OF PRP or microfracture only for osteochondral lesions of the knee: a five-year retrospective evaluation. J Biol Regul Homeost Agents. 2016;30(4 Suppl 1):41-49.

23. Маланин Д.А., Трегубов А.С., Демещенко М.В., Черезов Л.Л. PRP–терапия при остеоартрите крупных суставов. Волгоград: Издательство ВолгГМУ; 2018:49. Доступно по: http://www.prplab.ru/docs/PRP-terapiya-pri-osteoartrite-krupnyh-sustavov.pdf. Ссылка активна на 25.10.2023.

24. Glynn LG, Mustafa A, Casey M, et al. Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care. Pilot Feasibility Stud. 2018;4:93. doi: 10.1186/s40814-018-0288-2

25. Третьяков А.А., Николаев В.И., Зиновкин Д.А., Сердюченко Н.С. Экспериментальная модель остеоартрита коленного сустава у крыс. Новости медико-биологических наук. 2020;20(4):90-97.

26. Huang GS, Peng YJ, Hwang DW, et al. Assessment of the efficacy of intra-articular platelet rich plasma treatment in an ACLT experimental model by dynamic contrast enhancement MRI of knee subchondral bone marrow and MRI T2* measurement of articular cartilage. Osteoarthritis Cartilage. 2021;29(5):718-727. doi: 10.1016/j.joca.2021.02.001

27. Azizi S, Kheirandish R, Farsinejad A, Rasouli N. The effect of intraarticular serum rich in growth factors (SRGF) on knee osteoarthritis in the rat model. Transfus Apher Sci. 2017;56(3):371-375. doi: 10.1016/j.transci.2017.02.006

28. Araya N, Miyatake K, Tsuji K, et al. Intra-articular Injection of Pure Platelet-Rich Plasma Is the Most Effective Treatment for Joint Pain by Modulating Synovial Inflammation and Calcitonin Gene-Related Peptide Expression in a Rat Arthritis Model. Am J Sports Med. 2020;48(8):2004-2012. doi: 10.1177/0363546520924011

29. Суббот А.М., Труфанов С.В., Шазбазян Н.П. Сравнительный анализ регенеративного потенциала производных крови на клеточной модели повреждения эпителия роговицы. Гены и клетки. 2021;16(1):64-68. doi: 10.23868/202104010


Review

For citations:


Tretyakov A.A., Zinovkin D.A., Karpenko F.N., Potapnev M.P., Nikolaev V.I., Pranjol M.Z. Pathomorphologic evaluation of intra-articular injections of soluble platelet-rich plasma for treatment of experimental osteoarthritis. Genij Ortopedii. 2024;30(1):90-98. https://doi.org/10.18019/1028-4427-2024-30-1-90-98. EDN: WNDTZQ

Views: 499


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1028-4427 (Print)
ISSN 2542-131X (Online)